Continued tirzepatide: Lost an additional 5.5% Total weight loss at 88 weeks: 25.3% 89.5% maintained at least 80% of their weight loss Switched to placebo: Regained weight Total weight loss at 88 weeks: 9.9% Only 16.6% maintained at least 80% of their weight loss This trial demonstrates that tirzepatide works best as ongoing treatment and that stopping medication typically leads to significant weight regain
LAMC1: laminin subunit gamma 1
Rotate between your right and left thigh each week, and cycle through your other approved sites (abdomen and upper arm) every two to three weeks to prevent lipohypertrophy
Compounded tirzepatide requires a prescription from a licensed healthcare provider, and it can only be obtained from a licensed compounding pharmacy
Available at: [Google Scholar] 58.Galicia-Garcia U, Benito-Vicente A, Jebari S, Larrea-Sebal A, Siddiqi H, Uribe KB, et al
Methods and materials Experimental design Four parallel groups of NC and PC male rats ( n = 49